$0.9504
0.03834.20%
At close: Jun 15, 5:00 PM EST
$0.9242
-0.0262-2.76%
After Hours: 6:51 PM EST
TScan Therapeutics Inc Earnings Estimates
TCRXNASDAQ
TScan Therapeutics Earnings Estimates, EPS & Revenue | NASDAQ:TCRX
TScan Therapeutics (TCRX) is scheduled to report Q2 earnings on August 11, 2026. Analysts estimate EPS of $-0.22 and quarterly revenue of $2.55M.
In the most recent quarter (Q1), TScan Therapeutics reported EPS of $-0.22, missing estimates of $-0.18 by 0.22%. Revenue came in at $982.00K, missing the estimate of $2.47M by 0.60%.
Over the last 4 quarters, TScan Therapeutics has averaged an EPS surprise of 0.21% and a revenue surprise of 0.44%.
Earnings Date
Aug 11
EPS Estimate
$-0.220
Quarterly Revenue Estimate
$2.55M
Annual Revenue
(as of Mar 31)
(as of Mar 31)
$9.14M
TScan Therapeutics Earnings History
Analyze the earnings history of TScan Therapeutics using advanced sorting and filters.
Loading calendar...
TScan Therapeutics (TCRX) Earnings Per Share
The chart below shows TScan Therapeutics's reported EPS compared to analyst estimates over recent quarters.
TScan Therapeutics (TCRX) Revenue
The chart below shows TScan Therapeutics's reported revenue compared to analyst estimates over recent quarters.
FAQ
When is TScan Therapeutics (NASDAQ:TCRX) reporting earnings?
TScan Therapeutics (TCRX) is scheduled to report earnings on August 11, 2026. The last reported earnings were for reported on May 6, 2026 for Q1.
What were the latest earnings per share (EPS) for TScan Therapeutics (NASDAQ:TCRX)?
The Actual EPS was $-0.22, which missed the estimate of $-0.18.
What were TScan Therapeutics’s (NASDAQ:TCRX) revenues?
The Actual Revenue was $982.00K, which missed the estimate of $2.47M.
